Invention Grant
- Patent Title: Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
- Patent Title (中): 口服唑来膦酸或相关化合物治疗腰痛的组合物
-
Application No.: US14686551Application Date: 2015-04-14
-
Publication No.: US09408860B2Publication Date: 2016-08-09
- Inventor: Herriot Tabuteau
- Applicant: Antecip Bioventures II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Brent A. Johnson; Louis C. Cullman
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K9/00 ; A61K9/20 ; A61K9/28
Abstract:
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
Public/Granted literature
- US20150216884A1 Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Low Back Pain Public/Granted day:2015-08-06
Information query
